Once our aptamers our generated, along with our work with Targeted Protein Delivery, we wish to parallely check out some ideas.
Diagnosis: By conjugating our aptamer with a light sensitive molecule, we hope to achieve for a tool which can help in diagnosis. Since reports have shown that p231 Tau can play a very important role in preclinical diagnosis of Alzheimer's, we would hope to develop this into an assay that can streamline the development of further diagnosis tools on CSF/plasma samples. This will help in a better understanding of the disease in a person in conjunction with other tests.